Gene · 774
Papers1,947
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,947
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of chemotherapy resistance in ovarian cancer. | Cancer Drug Resist | 2022 | 35800369 | PubTator, text mining | PubMed |
| Prioritizing Suggestive Candidate Genes in Migraine: An Opinion. | Front Neurol | 2022 | 35785356 | PubTator, text mining | PubMed |
| Urinary extracellular vesicle as a potential biomarker of exercise-induced fatigue in young adult males. | Eur J Appl Physiol | 2022 | 35781843 | PubTator, text mining | PubMed |
| High expression of N-type calcium channel indicates a favorable prognosis in gliomas. | Medicine (Baltimore) | 2022 | 35777045 | PubTator, text mining | PubMed |
| Identification of ultra-rare genetic variants in pediatric acute onset neuropsychiatric syndrome (PANS) by exome and whole genome sequencing. | Sci Rep | 2022 | 35773312 | PubTator, text mining | PubMed |
| Computational study of interactions of anti-cancer drug eribulin with human tubulin isotypes. | Phys Chem Chem Phys | 2022 | 35766982 | PubTator, text mining | PubMed |
| A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect. | Front Pharmacol | 2022 | 35754473 | PubTator, text mining | PubMed |
| Global analyses of mRNA expression in human sensory neurons reveal eIF5A as a conserved target for inflammatory pain. | FASEB J | 2022 | 35747924 | PubTator, text mining | PubMed |
| When Does the Human Embryonic Heart Start Beating? A Review of Contemporary and Historical Sources of Knowledge about the Onset of Blood Circulation in Man. | J Cardiovasc Dev Dis | 2022 | 35735816 | PubTator, text mining | PubMed |
| Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in Current Management. | Medeni Med J | 2022 | 35735183 | PubTator, text mining | PubMed |
| Synthetic Heparan Sulfate Hydrogels Regulate Neurotrophic Factor Signaling and Neuronal Network Activity. | ACS Appl Mater Interfaces | 2022 | 35708492 | PubTator, text mining | PubMed |
| Nuclear βII-Tubulin and its Possible Utility in Cancer Diagnosis, Prognosis and Treatment. | Front Cell Dev Biol | 2022 | 35706904 | PubTator, text mining | PubMed |
| Artificial intelligence, nano-technology and genomic medicine: The future of anaesthesia. | J Anaesthesiol Clin Pharmacol | 2022 | 35706631 | PubTator, text mining | PubMed |
| Anti-tumor pharmacology of natural products targeting mitosis. | Cancer Biol Med | 2022 | 35699421 | PubTator, text mining | PubMed |
| Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression. | Neurochem Res | 2022 | 35689787 | PubTator, text mining | PubMed |
| Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls. | J Clin Med | 2022 | 35683390 | PubTator, text mining | PubMed |
| Rare CACNA1H and RELN variants interact through mTORC1 pathway in oligogenic autism spectrum disorder. | Transl Psychiatry | 2022 | 35668055 | PubTator, text mining | PubMed |
| Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma. | Front Genet | 2022 | 35664298 | PubTator, text mining | PubMed |
| Complex effects on CaV2.1 channel gating caused by a CACNA1A variant associated with a severe neurodevelopmental disorder. | Sci Rep | 2022 | 35655070 | PubTator, text mining | PubMed |
| Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy. | Biomedicines | 2022 | 35625921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/774/papers?page=18